Please login to the form below

Not currently logged in
Email:
Password:

Protein coat for nanowires could lower harmful medicine dosages

Scientists in Idaho and Korea reveal the development of a protein coating which could turn nanowires into a new drug delivery system, helping to target doses of medicines harmful to humans

Scientists in Idaho and Korea have revealed the development of a protein coating which could turn nanowires into a new drug delivery system, helping to target doses of medicines harmful to humans.

The study leaders at the University of Idaho, Gregory Bohach, David McIlroy and Carolyn Hovde, reported that nanowires and other nanomaterials (NM), which are 50,000 times smaller in diameter than a human hair, could be used penetrate tumours more easily.

The researchers reported that nanowires coated with the protein fibronectin penetrated cells more easily than uncoated nanowires. They added that the wires could also be coated with antibodies or other materials which home in on abnormal cells, while sparing normal cells.

In experiments with human and bovine cells, results showed that coated nanowires could enter and deliver a toxic agent called StxA1 which then killed the cells.

Professor Bohach said: "This indicates that nanowires can carry StxA1 and potentially other toxic or therapeutic agents into cells."

4th September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics